Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwan Bezard

Showing results (251-260 of 298) with videos related to

Pageof 30
Sort By:
Neurobiology of Disease|May 19, 2020
Evidence for the spread of human-derived mutant huntingtin protein in mice and non-human primatesPhilippe Gosset, Alexander Maxan, Melanie Alpaugh, et al.
Annals of Neurology|November 19, 2013
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeysAriadna Recasens, Benjamin Dehay, Jordi Bové, et al.
ACS Nano|May 16, 2025
Ultrashort Carbon Nanotubes with Luminescent Color Centers Are Bright NIR-II NanoemittersSomen Nandi, Quentin Gresil, Benjamin P Lambert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 13, 2012
L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptorAmandine Berthet, Erwan Bezard, Gregory Porras, et al.
Neurobiology of Disease|March 18, 2023
Functional and neuropathological changes induced by injection of distinct alpha-synuclein strains: A pilot study in non-human primatesAudrey Fayard, Alexis Fenyi, Sonia Lavisse, et al.
Cell Reports|February 22, 2018
Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson's Disease ModelsAngelo Iannielli, Simone Bido, Lucrezia Folladori, et al.
Neurobiology of Disease|December 6, 2021
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activitySalvatore Novello, Daniela Mercatelli, Federica Albanese, et al.
Nature Reviews. Drug Discovery|October 4, 2006
Novel pharmacological targets for the treatment of Parkinson's diseaseAnthony H V Schapira, Erwan Bezard, Jonathan Brotchie, et al.
Neurobiology of Disease|July 14, 2023
Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degenerationMarcello Serra, Anna Di Maio, Valentina Bassareo, et al.
Human Molecular Genetics|May 19, 2017
Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegenerationFederico N Soria, Michel Engeln, Marta Martinez-Vicente, et al.
Pageof 30

Showing results (251-260 of 298) with videos related to

Sort By:
Pageof 30
Neurobiology of Disease|May 19, 2020
Evidence for the spread of human-derived mutant huntingtin protein in mice and non-human primatesPhilippe Gosset, Alexander Maxan, Melanie Alpaugh, et al.
Annals of Neurology|November 19, 2013
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeysAriadna Recasens, Benjamin Dehay, Jordi Bové, et al.
ACS Nano|May 16, 2025
Ultrashort Carbon Nanotubes with Luminescent Color Centers Are Bright NIR-II NanoemittersSomen Nandi, Quentin Gresil, Benjamin P Lambert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 13, 2012
L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptorAmandine Berthet, Erwan Bezard, Gregory Porras, et al.
Neurobiology of Disease|March 18, 2023
Functional and neuropathological changes induced by injection of distinct alpha-synuclein strains: A pilot study in non-human primatesAudrey Fayard, Alexis Fenyi, Sonia Lavisse, et al.
Cell Reports|February 22, 2018
Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson's Disease ModelsAngelo Iannielli, Simone Bido, Lucrezia Folladori, et al.
Neurobiology of Disease|December 6, 2021
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activitySalvatore Novello, Daniela Mercatelli, Federica Albanese, et al.
Nature Reviews. Drug Discovery|October 4, 2006
Novel pharmacological targets for the treatment of Parkinson's diseaseAnthony H V Schapira, Erwan Bezard, Jonathan Brotchie, et al.
Neurobiology of Disease|July 14, 2023
Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degenerationMarcello Serra, Anna Di Maio, Valentina Bassareo, et al.
Human Molecular Genetics|May 19, 2017
Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegenerationFederico N Soria, Michel Engeln, Marta Martinez-Vicente, et al.
Pageof 30